GCP
ETON icon

GSA Capital Partners’s Eton Pharmaceutcials ETON Stock Holding History

GSA Capital Partners’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-14,785
Closed -$321K – 1779
2025
Q3 		$321K Buy
+14,785
New +$245K 0.03% 1163
2022
Q2 		– Sell
-24,475
Closed -$107K – 1502
2022
Q1 		$107K Sell
24,475
-15,342
-39% -$60.3K 0.01% 1283
2021
Q4 		$171K Sell
39,817
-42,497
-52% -$203K 0.02% 1250
2021
Q3 		$415K Buy
82,314
+24,917
+43% +$130K 0.04% 810
2021
Q2 		$354K Buy
57,397
+17,333
+43% +$128K 0.04% 837
2021
Q1 		$293K Buy
+40,064
New +$342K 0.05% 660

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

GSA Capital Partners's ETON Position: Q4 2025 in Review

GSA Capital Partners sold out of Eton Pharmaceutcials (ETON) in Q4 2025, closing a stake of 14,785 shares — an estimated $321K sold.

GSA Capital Partners first reported a position in ETON in Q1 2021 and held it in 6 quarters. The position peaked at $415K in Q3 2021. 104 funds tracked by Wall St. Rank hold ETON as of Q4 2025.

  • GSA Capital Partners reported no remaining Eton Pharmaceutcials position as of Q4 2025 after selling out during the quarter.
  • GSA Capital Partners sold 14,785 Eton Pharmaceutcials shares in Q4 2025, an estimated $321K.
  • GSA Capital Partners first reported a position in Eton Pharmaceutcials in Q1 2021 and held it in 6 quarters.
  • GSA Capital Partners's Eton Pharmaceutcials position peaked at $415K in Q3 2021.
  • 104 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q4 2025.

Based on GSA Capital Partners's 13F filing for Q4 2025, filed 6 Feb 2026.